BLEG (Branded Legacy) EV-to-EBIT: -0.07 (As of Jul. 02, 2026)


What is Branded Legacy EV-to-EBIT?

Branded Legacy BLEG EV-to-EBIT is -0.07 as of Jul. 02, 2026.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Branded Legacy's Enterprise Value is $0.02 Mil. Branded Legacy's EBIT for the trailing twelve months (TTM) ended in Dec. 2021 was $-0.31 Mil. Therefore, Branded Legacy's EV-to-EBIT for today is -0.07.

The historical rank and industry rank for Branded Legacy's EV-to-EBIT or its related term are showing as below:

BLEG's EV-to-EBIT is not ranked *
in the Drug Manufacturers industry.
Industry Median: 15.8
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Branded Legacy's Enterprise Value for the quarter that ended in Dec. 2021 was $15.77 Mil. Branded Legacy's EBIT for the trailing twelve months (TTM) ended in Dec. 2021 was $-0.31 Mil. Branded Legacy's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2021 was -1.99%.


Branded Legacy  (OTCPK:BLEG) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Branded Legacy's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2021 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2021 ) =EBIT / Enterprise Value (Q: Dec. 2021 )
=-0.314/15.765
=-1.99 %

Branded Legacy's Enterprise Value for the quarter that ended in Dec. 2021 was $15.77 Mil.
Branded Legacy's EBIT for the trailing twelve months (TTM) ended in Dec. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.31 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Branded Legacy EV-to-EBIT Related Terms


Branded Legacy EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Branded Legacy's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Branded Legacy EV-to-EBIT Chart

Branded Legacy Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EV-to-EBIT
Get a 7-Day Free Trial -687.16 -45.80 -4.94 -32.64 -50.32

Branded Legacy Quarterly Data
Dec15 Dec16 Dec17 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -32.64 -61.04 -18.25 10.70 -50.32

BLEG vs UPDC, RIBT, GDMK: EV-to-EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Branded Legacy's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Branded Legacy EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Branded Legacy's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Branded Legacy's EV-to-EBIT falls into.



Branded Legacy EV-to-EBIT Calculation

Branded Legacy's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.023/-0.314
=-0.07

Branded Legacy's current Enterprise Value is $0.02 Mil.
Branded Legacy's EBIT for the trailing twelve months (TTM) ended in Dec. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.31 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-EBIT →
What does a EV-to-EBIT of -0.07 mean?
Branded Legacy (BLEG) has a EV-to-EBIT of -0.07 as of Jul. 02, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Branded Legacy and its competitors.
Is Branded Legacy's EV-to-EBIT too high?
Branded Legacy's current EV-to-EBIT is -0.07.
How does Branded Legacy's EV-to-EBIT compare to UPDC and RIBT?
Branded Legacy's EV-to-EBIT of -0.07 can be compared against companies in the Drug Manufacturers industry. The industry median EV-to-EBIT is 15.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Drug Manufacturers company?
The median EV-to-EBIT among Drug Manufacturers companies is 15.80, based on 689 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Branded Legacy and its competitors. For the Drug Manufacturers industry, the median EV-to-EBIT is 15.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Branded Legacy's current EV-to-EBIT is -0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Branded Legacy stock overvalued right now?
Branded Legacy (BLEG) has a current EV-to-EBIT of -0.07. The current EV-to-EBIT is -0.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Branded Legacy (BLEG), the current EV-to-EBIT is -0.07 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Branded Legacy Business Description

Address 751 North Drive, Suite 9, Melbourne, FL, USA, 32934
Branded Legacy Inc provides high-level strategic advisory and operational transformation services focused on complex research, clinical development, and data-intensive organizations. Branded Legacy specializes in supporting large-scale international research consortia, platform clinical trials, and institutional/government data science initiatives. The core operations center on diagnosing operational inefficiencies, redesigning legacy systems, and implementing transparent, high-impact solutions that deliver measurable results.